Biomea Fusion BMEA
NASDAQ BMEA
$0.59 +0.04 (+7.92%)
As of: Nov 11, 2026 · 11:31 AM EST

Biomea Fusion (BMEA) Return on Sales [ROS] (2024 - 2026)

Updated

Analysis

Biomea Fusion (BMEA) Return on Sales [ROS] (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 34.46%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 24.35%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 36.01%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 30.74%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 29.12%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 35.79%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 41.71%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 32.98%
10 Biomea Fusion 39.97 Mn -121.76 Mn - -4,855.06%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -4,855.06%
Jun 30, 2026 -4,001.88%
Mar 31, 2026 -2,970.70%
Dec 31, 2025 -2,045.20%
Sep 30, 2025 -3,955.32%
Jun 30, 2025 -6,885.44%
Mar 31, 2025 -6,602.67%
Dec 31, 2024 -3,895.60%
Sep 30, 2024 -2,718.77%
Jun 30, 2024 -2,398.15%
Mar 31, 2024 -2,055.01%
API Access

Biomea Fusion Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=BMEA&period=max&api_key=YOUR_API_KEY